Home

Alembic Pharmaceuticals Ltd Quarterly Result

Image

Alembic Pharmaceuticals Ltd

NSE: APLLTD

Net Profit - Last Quarter

₹ 153.14 Cr.

Last updated on: Jan 15, 2025

Key Highlights

  • The revenue of Alembic Pharmaceuticals Ltd for the Sep '24 is ₹ 1678 crore as compare to the Jun '24 revenue of ₹ 1564 crore. This represent the growth of 7.307478%.
  • The ebitda of Alembic Pharmaceuticals Ltd for the Sep '24 is ₹ 269.74 crore as compare to the Jun '24 ebitda of ₹ 239.25 crore. This represent the growth of 12.743987%.
  • The net profit of Alembic Pharmaceuticals Ltd for the Sep '24 is ₹ 153.14 crore as compare to the Jun '24 net profit of ₹ 134.54 crore. This represent the growth of 13.82489%.

Results Analysis

Market Price of Alembic Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Alembic Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
15 Jan 20251004.15
14 Jan 20251009.15
13 Jan 20251003.05
10 Jan 20251008.95
09 Jan 20251054.9
08 Jan 20251064.85
07 Jan 20251091.05
06 Jan 20251062.65
03 Jan 20251052.15
02 Jan 20251050.55

Historical Revenue of Alembic Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Alembic Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Alembic Pharmaceuticals Ltd

No data available

* All values are in crore

Alembic Pharmaceuticals Ltd News Hub

Alembic Pharma receives USFDA approval for Dabigatran Etexilate Capsules

Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration (USFDA) f

Read more

13 Aug 2024

Alembic Pharma gets US FDA nod for anticoagulant Dabigatran

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Pradaxa

Read more

13 Aug 2024

Alembic Pharmaceuticals Ltd leads losers in 'A' group

Steel Authority of India Ltd, IFCI Ltd, Coffee Day Enterprises Ltd and Orient Cement Ltd are among t

Read more

09 Aug 2024

Alembic Pharma Q1 PAT rises 12% YoY to Rs 135 cr

Revenue from operations grew 5.09% year on year (YoY) to Rs 1,561.73 crore in the quarter ended 30 J

Read more

08 Aug 2024

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

Feb 2023

Transcript

Nov 2022

Transcript

Aug 2022

Transcript

May 2022

Transcript

Nov 2021

Transcript

Aug 2021

Transcript

May 2021

Transcript

FAQs for Quarterly Results of Alembic Pharmaceuticals Ltd

What key financial metrics are included in Alembic Pharmaceuticals Ltd's quarterly results?

Key financial metrics in Alembic Pharmaceuticals Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Alembic Pharmaceuticals Ltd announce its quarterly results?

Alembic Pharmaceuticals Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Alembic Pharmaceuticals Ltd's quarterly performance impact its stock price?

Alembic Pharmaceuticals Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Alembic Pharmaceuticals Ltd's quarterly results on dividends?

The impact of Alembic Pharmaceuticals Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Alembic Pharmaceuticals Ltd's quarterly results?

Yes, Alembic Pharmaceuticals Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions